PPP2R1A and ovarian cancer: Studies have found that PPP2R1A has a high-frequency mutation in serous endometrial carcinoma, indicating a poor prognosis (Nagendra et al., 2012), we found that there were more PPP2R1A mutations in ovarian cancer than in other genes.